[] Patient should be thoroughly screened for a history of pancreatitis or medullary thyroid carcinoma, due to GLP-1 RAs potential exacerbation of these diseases
Additionally, patients receiving GLP-1 medications often have metabolic conditions that independently affect cancer risk, making it challenging to isolate drug effects
Patients with mild to moderate hepatic or renal impairment may experience prolonged drug exposure
Regarding weight management, its crucial to remember that everyone is unique, and each journey is different
How much weight can I expect to lose with semaglutide
From superficial wounds to deep structural injuries, animal studies show consistent improvements in healing speed, tissue quality, and functional recovery